Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 11Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 15NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Carcinoma, Non-Small-Cell Lung 25Ovarian Neoplasms 23Breast Neoplasms 22Lung Neoplasms 19Lymphoma 18Carcinoma, Ovarian Epithelial 18Neoplasm Metastasis 14Colorectal Neoplasms 14Squamous Cell Carcinoma of Head and Neck 12Sarcoma 12Head and Neck Neoplasms 12Urinary Bladder Neoplasms 10Prostatic Neoplasms 10Colonic Neoplasms 10Central Nervous System Neoplasms 10Astrocytoma 10Rectal Neoplasms 9Multiple Myeloma 9Uterine Cervical Neoplasms 8Oligodendroglioma 8Mycosis Fungoides 8Fallopian Tube Neoplasms 8Adenocarcinoma of Lung 8Stomach Neoplasms 7Recurrence 7Melanoma 7Medulloblastoma 7Brain Neoplasms 7Sezary Syndrome 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × NETWORK × Breast Carcinoma In Situ × Clear all
NCT00002934 2023-06-22

Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ

Eastern Cooperative Oncology Group

Phase 2 Terminated
711 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00088972 2018-08-10

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

SWOG Cancer Research Network

Phase 2 Terminated
8 enrolled 5 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡